Annual Current Liabilities
$45.53 M
+$13.10 M+40.40%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual total current liabilities is $45.53 million, with the most recent change of +$13.10 million (+40.40%) on December 31, 2023.
- During the last 3 years, PLX annual current liabilities has fallen by -$40.94 million (-47.35%).
- PLX annual current liabilities is now -47.35% below its all-time high of $86.47 million, reached on December 31, 2020.
Performance
PLX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$24.22 M
-$33.75 M-58.22%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly total current liabilities is $24.22 million, with the most recent change of -$33.75 million (-58.22%) on September 30, 2024.
- Over the past year, PLX quarterly current liabilities has dropped by -$19.14 million (-44.14%).
- PLX quarterly current liabilities is now -74.84% below its all-time high of $96.25 million, reached on June 30, 2021.
Performance
PLX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
PLX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.4% | -44.1% |
| 3 y3 years | -47.4% | -44.1% |
| 5 y5 years | +79.6% | -44.1% |
PLX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.4% | -58.2% | +4.8% |
| 5 y | 5-year | -47.4% | +40.4% | -74.8% | +4.8% |
| alltime | all time | -47.4% | >+9999.0% | -74.8% | >+9999.0% |
Protalix BioTherapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $24.22 M(-58.2%) |
| Jun 2024 | - | $57.97 M(+5.7%) |
| Mar 2024 | - | $54.83 M(+20.4%) |
| Dec 2023 | $45.53 M(+40.4%) | $45.53 M(+5.0%) |
| Sep 2023 | - | $43.36 M(+87.6%) |
| Jun 2023 | - | $23.11 M(-26.7%) |
| Mar 2023 | - | $31.52 M(-2.8%) |
| Dec 2022 | $32.43 M(-2.3%) | $32.43 M(-5.5%) |
| Sep 2022 | - | $34.30 M(+10.8%) |
| Jun 2022 | - | $30.96 M(-12.4%) |
| Mar 2022 | - | $35.33 M(+6.5%) |
| Dec 2021 | $33.18 M(-61.6%) | $33.18 M(-22.4%) |
| Sep 2021 | - | $42.76 M(-55.6%) |
| Jun 2021 | - | $96.25 M(+19.0%) |
| Mar 2021 | - | $80.86 M(-6.5%) |
| Dec 2020 | $86.47 M(+115.2%) | $86.47 M(+97.0%) |
| Sep 2020 | - | $43.90 M(+3.5%) |
| Jun 2020 | - | $42.41 M(-10.9%) |
| Mar 2020 | - | $47.63 M(+18.6%) |
| Dec 2019 | $40.17 M(+58.5%) | $40.17 M(+20.6%) |
| Sep 2019 | - | $33.32 M(+28.2%) |
| Jun 2019 | - | $25.99 M(-3.9%) |
| Mar 2019 | - | $27.04 M(+6.6%) |
| Dec 2018 | $25.35 M(+11.4%) | $25.35 M(+74.2%) |
| Sep 2018 | - | $14.55 M(-3.5%) |
| Jun 2018 | - | $15.07 M(-29.9%) |
| Mar 2018 | - | $21.50 M(-5.5%) |
| Dec 2017 | $22.75 M(-65.6%) | $22.75 M(-14.4%) |
| Sep 2017 | - | $26.59 M(+39.1%) |
| Jun 2017 | - | $19.12 M(-5.8%) |
| Mar 2017 | - | $20.29 M(-69.4%) |
| Dec 2016 | $66.21 M(+489.3%) | $66.21 M(+540.8%) |
| Sep 2016 | - | $10.33 M(-9.8%) |
| Jun 2016 | - | $11.46 M(+23.5%) |
| Mar 2016 | - | $9.28 M(-17.4%) |
| Dec 2015 | $11.23 M(-82.5%) | $11.23 M(-50.8%) |
| Sep 2015 | - | $22.85 M(-10.4%) |
| Jun 2015 | - | $25.52 M(-3.9%) |
| Mar 2015 | - | $26.55 M(-58.7%) |
| Dec 2014 | $64.35 M(+141.1%) | $64.35 M(+163.9%) |
| Sep 2014 | - | $24.38 M(-10.3%) |
| Jun 2014 | - | $27.18 M(+1.5%) |
| Mar 2014 | - | $26.78 M(+0.3%) |
| Dec 2013 | $26.70 M(+3.7%) | $26.70 M(+5.8%) |
| Sep 2013 | - | $25.23 M(-5.3%) |
| Jun 2013 | - | $26.63 M(+9.1%) |
| Mar 2013 | - | $24.41 M(-5.2%) |
| Dec 2012 | $25.75 M(+37.8%) | $25.75 M(+26.0%) |
| Sep 2012 | - | $20.43 M(-4.2%) |
| Jun 2012 | - | $21.33 M(+20.4%) |
| Mar 2012 | - | $17.72 M(-5.2%) |
| Dec 2011 | $18.69 M | $18.69 M(+2.1%) |
| Sep 2011 | - | $18.31 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2011 | - | $20.28 M(+0.8%) |
| Mar 2011 | - | $20.13 M(+6.5%) |
| Dec 2010 | $18.90 M(-12.2%) | $18.90 M(-7.7%) |
| Sep 2010 | - | $20.49 M(+30.1%) |
| Jun 2010 | - | $15.75 M(-20.5%) |
| Mar 2010 | - | $19.82 M(-8.0%) |
| Dec 2009 | $21.53 M(+289.5%) | $21.53 M(+212.0%) |
| Sep 2009 | - | $6.90 M(+11.0%) |
| Jun 2009 | - | $6.21 M(+9.2%) |
| Mar 2009 | - | $5.69 M(+3.0%) |
| Dec 2008 | $5.53 M(+46.9%) | $5.53 M(+25.6%) |
| Sep 2008 | - | $4.40 M(+1.4%) |
| Jun 2008 | - | $4.34 M(+3.2%) |
| Mar 2008 | - | $4.21 M(+11.8%) |
| Dec 2007 | $3.76 M(+65.9%) | $3.76 M(+4.1%) |
| Sep 2007 | - | $3.61 M(+33.9%) |
| Jun 2007 | - | $2.70 M(+21.0%) |
| Mar 2007 | - | $2.23 M(-1.7%) |
| Dec 2006 | $2.27 M(+168.4%) | $2.27 M(>+9900.0%) |
| Sep 2006 | - | $12.10 K(-10.4%) |
| Jun 2006 | - | $13.50 K(-76.8%) |
| Mar 2006 | - | $58.10 K(-93.1%) |
| Dec 2005 | $845.00 K(+1107.1%) | $845.00 K(+1262.9%) |
| Sep 2005 | - | $62.00 K(+7.3%) |
| Jun 2005 | - | $57.80 K(-16.7%) |
| Mar 2005 | - | $69.40 K(-0.9%) |
| Dec 2004 | $70.00 K(-11.2%) | $70.00 K(+14.2%) |
| Sep 2004 | - | $61.30 K(-9.1%) |
| Jun 2004 | - | $67.40 K(+9.4%) |
| Mar 2004 | - | $61.60 K(-21.8%) |
| Dec 2003 | $78.80 K(-0.4%) | $78.80 K(+24.7%) |
| Sep 2003 | - | $63.20 K(+2.4%) |
| Jun 2003 | - | $61.70 K(-23.9%) |
| Mar 2003 | - | $81.10 K(+2.5%) |
| Dec 2002 | $79.10 K(+2.3%) | $79.10 K(+20.9%) |
| Sep 2002 | - | $65.40 K(+6.5%) |
| Jun 2002 | - | $61.40 K(-12.4%) |
| Mar 2002 | - | $70.10 K(-9.3%) |
| Dec 2001 | $77.30 K(-86.2%) | $77.30 K(-42.3%) |
| Sep 2001 | - | $134.00 K(+1.9%) |
| Jun 2001 | - | $131.50 K(-80.7%) |
| Mar 2001 | - | $680.50 K(+21.4%) |
| Dec 2000 | $560.60 K(+22.0%) | $560.60 K(+43.3%) |
| Sep 2000 | - | $391.30 K(-0.5%) |
| Jun 2000 | - | $393.20 K(-7.0%) |
| Mar 2000 | - | $422.80 K(-8.0%) |
| Dec 1999 | $459.40 K(-66.5%) | $459.40 K(-14.3%) |
| Sep 1999 | - | $535.90 K(-21.4%) |
| Jun 1999 | - | $682.10 K(-41.2%) |
| Mar 1999 | - | $1.16 M |
| Dec 1998 | $1.37 M(+1443.0%) | - |
| Dec 1997 | $88.80 K(+11.0%) | - |
| Dec 1996 | $80.00 K | - |
FAQ
- What is Protalix BioTherapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual current liabilities year-on-year change?
- What is Protalix BioTherapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly current liabilities year-on-year change?
What is Protalix BioTherapeutics annual total current liabilities?
The current annual current liabilities of PLX is $45.53 M
What is the all time high annual current liabilities for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual total current liabilities is $86.47 M
What is Protalix BioTherapeutics annual current liabilities year-on-year change?
Over the past year, PLX annual total current liabilities has changed by +$13.10 M (+40.40%)
What is Protalix BioTherapeutics quarterly total current liabilities?
The current quarterly current liabilities of PLX is $24.22 M
What is the all time high quarterly current liabilities for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly total current liabilities is $96.25 M
What is Protalix BioTherapeutics quarterly current liabilities year-on-year change?
Over the past year, PLX quarterly total current liabilities has changed by -$19.14 M (-44.14%)